Zachary S. Wallace

Zachary S. Wallace

Auto-generated profile, based on publicly available information

Zachary S. Wallace

Division of Human Genomics and Precision Medicine, Department of Medicine, University of California at San Diego, La Jolla CA 92093

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2022 in Nature
Verified
Journal Article
Closed access
PDF file
MDMarciela M. DeGrace
Marciela M. DeGrace
EGElodie Ghedin
Elodie Ghedin
Matthew FriemanMatthew Frieman
Matthew Frieman
Florian KrammerFlorian Krammer
Florian Krammer
AGAlba Grifoni
Alba Grifoni
MSMehul Suthar
Mehul Suthar

24 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ILIngoo Lee
Ingoo Lee
ZWZachary S. Wallace
Zachary S. Wallace
YWYuqi Wang
Yuqi Wang
SPSungjoon Park
Sungjoon Park
HNHojung Nam
Hojung Nam
TITrey Ideker
Trey Ideker
Genome-wide association studies have linked millions of genetic variants to biomedical phenotypes, but their utility has been limited by lack of mechanistic understanding and widespread epistatic interactions. Recently, Transformer models have emerged as powerful machine learning architectures with potential to address these and other challenges. Here we introduce the Genotype-to-Phenotype Transformer (G2PT), a framework for modeling hierarchical information flow among variants, genes, multigenic systems, and phenotypes. As proof-of-concept, we train G2PT to model the genetics of metabolic traits including insulin resistance (serum triglycerides-to-HDL ratio), LDL and type-2 diabetes. G2PT predicts these traits with accuracy exceeding state-of-the-art and, unlike other polygenic models, extends to distinct populations not used for training. Predictions of insulin resistance are based on >1,395 variants within 20 systems and include epistatic interactions among variants, e.g. between APOA4 and CETP in phospholipid transfer. This work positions hierarchical graph transformers as a next-generation approach to polygenic risk.

10 August 2022 in medRxiv
Verified
Preprint
Open access
PDF file
ZWZachary S. Wallace
Zachary S. Wallace
JDJames Davis
James Davis
ANAnna Maria Niewiadomska
Anna Maria Niewiadomska
RORobert D. Olson
Robert D. Olson
MSMaulik Shukla
Maulik Shukla
RSRichard Scheuermann
Richard Scheuermann
Since the beginning of the COVID-19 pandemic, SARS-CoV-2 has demonstrated its ability to rapidly and continuously evolve, leading to the emergence of thousands of different sequence variants, many with distinctive phenotypic properties. Fortunately, the broad availability of next generation sequencing (NGS) technologies across the globe has produced a wealth of SARS- CoV-2 genome sequences, offering a comprehensive picture of how this virus is evolving so that accurate diagnostics and reliable therapeutics for COVID-19 can be maintained. The millions of SARS-CoV-2 sequences deposited into genomic sequencing databases, including GenBank, BV-BRC, and GISAID are annotated with the dates and geographical regions of sample collection, and can be aligned to the Wuhan-Hu-1 reference genome to extract the constellation of nucleotide and amino acid substitutions. By aggregating these data into concise datasets, the spread of variants through space and time can be assessed. Variant tracking efforts have focused on the spike protein due to its critical role in viral tropism and antibody neutralization. To identify emerging variants of concern as early as possible, we developed a computational pipeline to process the genomic data from public databases and assign risk scores based on both epidemiological and functional parameters. Epidemiological dynamics are used to identify variants exhibiting substantial growth over time and across geographical regions. In addition, experimental data that quantify Spike protein regions critical for adaptive immunity are used to predict variants with consequential immunogenic or pathogenic impacts. These growth assessment and functional impact scores are combined to produce a Composite Score for any set of Spike substitutions detected. With this systematic approach to routinely score and rank emerging variants, we have established a method to identify threatening variants early and prioritize them for experimental evaluation.